High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 15376178.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The occurrence of in-transit metastases in patients with a tumour-positive sentinel node varies greatly between centres and it has been suggested that the incidence is high in this patient group. The incidence of in-transit metastases in 61 patients who had lymph node dissection because of a tumour-positive sentinel node was compared with that in 60 patients who had palpable nodal metastases dissected. The incidence of in-transit metastases was 23 per cent in patients with a positive sentinel node and 8 per cent in those with palpable nodes (P = 0.027). Sentinel node biopsy was associated with a higher risk of in-transit metastases. This finding does not support the routine use of sentinel node biopsy in the management of melanoma.
Medical subject headings
- Lymphatic Metastasis
- Melanoma
- Neoplasm Seeding
- Sentinel Lymph Node Biopsy
- Skin Neoplasms